Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.

J Clin PsycholJun 15, 2026 (epub)
Clinical ResearchPsychiatryOpen access

Lucas Cruz, Fernando R Beserra, Julia M K Freind et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined the use of music in psychedelic-assisted psychotherapy (PAP) across 36 articles, focusing on its selection and impact on treatment outcomes. The review highlighted that 25 articles discussed music use, primarily in the context of treating depressive disorders and PTSD with psilocybin and MDMA. The findings revealed significant variability in music selection and protocols.

Key findings

  • 25 out of 36 articles discussed music use in psychedelic-assisted psychotherapy.
  • Music was predominantly used in studies addressing depressive disorders and PTSD.
  • There was considerable variation in music selection and procedures across studies.
  • No standardized protocol for music use in PAP was identified.

Why it matters

Understanding the role of music in PAP can enhance therapeutic outcomes and inform future research. Clinicians may consider the contextual elements that influence patient experiences during treatment.

Source

PubMed · PMID 42296474Free full text on PubMed Central

Published in J Clin Psychol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.